Atrial Fibrillation Therapy

ISBN-13: 9781447154747 / Angielski / Miękka / 2013 / 188 str.

Gheorghe-Andrei Dan; Antoni Bayes de Luna; John Camm

Opis

The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This book assists trainees, recertifying physicians, practicing physicians and other professional staff in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply new diagnostic tools for selecting the best treatment options for AF patients.

Spis treści

Epidemiology, burden and unmet needs in atrial fibrillation.- Inside Molecular Mechanisms and pharmacological Targets of Atrial Fibrillation.- Novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.- Upstream therapy in the treatment of atrial fibrillation.- Drug therapy for rhythm and rate control in Atrial Fibrillation.- Changing the paradigm to understand and manage Atrial Fibrillation.- Guidelines and current recommendations in Atrial Fibrillation.

Blurb

This book presents the current evidence and practice in the pharmacological treatment of atrial fibrillation (AF). AF management has changed significantly in recent years as a new era has begun for the prevention of stroke, one of the most devastating complications of AF. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge and the enormous amount of research is revealing new treatment opportunities at a dizzying pace.

While new classes of antithrombotic drugs for AF treatment are still in their infancy, recent research is revealing how these can be applied with optimal efficacy. Atrial Fibrillation Therapy includes practical information for readers on applying the guidelines developed as a result of the increased pharmacotherapeutic understanding. This book also guides trainees, recertifying physicians, and practicing physicians in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply the new diagnostic tools for selecting the best treatment options for AF patients.

• Discusses new diagnostic tools for selecting therapies for AF patients
• Presents recent research in a highly practical, easy reference style
• Emphasis on a just-the-facts approach to the treatment options in AF